A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models
Dharaminder Singh(CN Bio Innovations (United Kingdom)), Clay W. Scott(AstraZeneca (United States)), John P. Wikswo(Vanderbilt University), Gregory B. Gerken(Vanderbilt University), Christopher E. Chambers(AstraZeneca (United Kingdom)), Emma Jane Davies(Aesthetic Surgery Center), Clayton M. Britt(Vanderbilt University), Sudhir P. Deosarkar(Temple University), Elaine Cadogan(AstraZeneca (Singapore)), Jacqueline H. L. Fok(AstraZeneca (United Kingdom)), Erik M. Werner(Vanderbilt University), Antonio Ramos Montoya(AstraZeneca (United Kingdom)), David K. Schaffer(Vanderbilt University), Francis D. Gibbons(AstraZeneca (United States)), Vikki Flemington(The Francis Crick Institute), Matthew P. Wagoner(AstraZeneca (United States)), Tomasz Kostrzewski(Cambridge Nutritional Sciences (United Kingdom)), Alysha Bray(CN Bio Innovations (United Kingdom)), David Hughes(CN Bio Innovations (United Kingdom)), Ronald S. Reiserer(Vanderbilt University), Jingwen Zhang(AstraZeneca (United States)), Kristin Fabre(AstraZeneca (United States))
Cited by 20
Related Papers
Using a magnetometer to image a two-dimensional current distribution
|Journal of Applied Physics|1989|465
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
|Annals of Oncology|2018|424
Recreating blood-brain barrier physiology and structure on chip: A novel neurovascular microfluidic bioreactor
|Biomicrofluidics|2015|414
Virtual electrodes in cardiac tissue: a common mechanism for anodal and cathodal stimulation
|Biophysical Journal|1995|359
Current injection into a two-dimensional anisotropic bidomain
|Biophysical Journal|1989|358